With 6 days left until Thanksgiving, gratitude today is for the research that develops new medicines and treatment methods.
I have been the direct recipient of this research, receiving Rituxan, a monoclonal antibody derived from mice, as a treatment for my lymphoma. Rituxan was the first Monoclonal Antibody (MAb) therapy developed for treating cancer in the 1990s. Rituxan and the other resulting MAb therapies have truly revolutionized the treatment of blood cancers, as well as breast and colorectal cancers.
I have also contributed to research by being part of a clinical trial involving two different methods of using Rituxan to treat lymphoma. One arm of the study gave "maintenance" treatments every few months, and the other, which I was randomized to, retreated at relapse.
Rituxan has been a true lifesaver for me. I have been treated 3 times in 8 1/2 years, and Rituxan has kept the disease under contol. I am truly fortunate and very grateful for the research that led to the development of this miracle drug, and many other amazing medications and treatments. Many thanks to the scientists, researchers, and clinical trial participants who make new treatment options available, and could possibly lead to a cure!
No comments:
Post a Comment